An evaluation study of change in auto-nervous system by suctioning of the aroma component.

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000039348
• Lead Sponsor: CPCC Company Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-02-29
• Study Start: 2021-02-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

1) Females who dislike the fragrance of black tea 2) Females who have smoking habit. 3) Females who are cold-sensitive constitution. 4) Females who are receiving medication due to treatment of some disease within current one month before the test. 5) Females who are receiving treatment for pollen allergy within current one month before the test. 6) Females with stuffy nose such as allergic rhinitis or females who can't identify the fragrance. 7) Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 8) Females with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. 9) Females who are pregnant or are lactating. 10) Females who have symptom of dermatologic disease such as atopic dermatitis. 11) Females who have undergone surgery on investigation objective portion within the past 6 months. 12) Females who are being treated by dentist, or females who plan to go dentist for receiving treatment. 13) Females who are participating the other clinical tests of medicines or foods. Females who participated other clinical tests of medicines or foods within a month prior to the current study. 14) Others who have been determined ineligible by principal investigator or sub-investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
*Evaluation of autonomic nervous system (pupil versus light reflection, skin temperature) * Evaluation of central nervous system (NIRS)

Secondary Outcome Measures

Name	Time	Method
* Salivary substances (Chromogranin A, Oxytocin) *Multiple mood scale (short version, 40 question) *VAS questionnaire about fragrance and mood * Incidence of adverse events and side effects